Immediate Impact

10 by Nobel laureates 2 from Science/Nature 77 standout
Sub-graph 1 of 23

Citing Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
4 intermediate papers

Works of Ashley Turka being referenced

bb2121 anti-BCMA CAR T-cell therapy in patients with relapsed/refractory multiple myeloma: Updated results from a multicenter phase I study.
2018
First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed/refractory multiple myeloma: Updated results.
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Ashley Turka 247 135 73 140 7 280
Gabriel O. Cole 222 109 74 118 4 264
A. Alonso 185 101 64 111 8 252
Jan Koedam 163 65 44 79 9 209
Qiu-Chuan Zhuang 148 64 66 63 7 202
Nawid Albinger 269 47 204 101 9 328
Paul Kerbs 150 137 82 146 11 298
Walid Warda 120 41 60 81 8 206
Alexander Tepper 154 30 53 116 6 241
Vladimir Senyukov 242 24 170 127 8 330
Marlene J. Carrasco-Alfonso 132 77 26 180 9 269

All Works

Loading papers...

Rankless by CCL
2026